Health News Releases

  • Today August 27
June 24, 2021 10:30
Oral-B Encourages Consumers to Brush up on Their Oral Care Regimen and Recognise Its Importance to Overall Body Health
Oral-B has teamed up with Scientific American and its Custom Media Division (SACM) to explore the latest research connecting oral health and overall health; as many are unaware of the impact chronic p
June 23, 2021 11:45
LegoChem Biosciences and Iksuda Therapeutics expand License Agreement for development of antibody-drug conjugates
Iksuda Therapeutics, the developer of a new generation of antibody drug conjugates (ADCs) with raised therapeutic index, today announced that it has expanded its research collaboration and License Agr
Sky Labs CART-I, the world’s first AI-based ring-type heart monitoring platform
June 23, 2021 10:14
Sky Labs Finalizes Series B Round Successfully Planning to Take Over Global Markets
Attracting USD 20 million investment, Sky Labs (CEO: Jack Lee), a global health care start-up, finalized Series B Round successfully. The accumulated amount of investment Sky Labs has attracted is USD
June 22, 2021 11:45
Jardiance® (empagliflozin) approved in Europe for the treatment of heart failure with reduced ejection fraction
The European Commission has granted marketing authorization for Jardiance® (empagliflozin) as a treatment for adults with symptomatic chronic heart failure with reduced ejection fraction (systolic hea
June 18, 2021 14:00
Pattern Computer Develops Accurate 15-Second COVID-19 Test
Pattern Computer,® Inc. (PCI) has developed a novel test for near real-time (15 sec) diagnosis of SARS-CoV-2 infections. In contrast with widely used antibody and PCR tests, which take at least 15 min
June 17, 2021 16:50
Smiths Medical Issues Worldwide Notification Regarding the Recall of Jelco® Hypodermic Needle-Pro® Fixed Needle Insulin Syringe With Skewed Graduation Markings
Smiths Medical has become aware of specific models and lots of Jelco® Hypodermic Needle-Pro® Fixed Needle Insulin Syringes that may exhibit skewed odd number line graduation markings on their syringe
June 17, 2021 14:45
Organon Completes Acquisition of Alydia Health - A Medical Device Company Focused on Postpartum Hemorrhage
Organon (NYSE: OGN), a global women’s healthcare company, today announced the completion of its acquisition of Alydia Health, a commercial-stage medical device company focused on preventing maternal m
June 16, 2021 13:40
Diabetes Center Berne Launches Its First Open Innovation Challenge and Supports the Most Promising Ideas Submitted With Coaching, Expertise and a Total of 200,000 USD in Funding
In the last few years, diabetes technology has made enormous progress in improving the lives of people living with diabetes. However, there is still a great unmet need for innovative technology soluti
June 15, 2021 14:40
Humanigen Initiates Submission for Lenzilumab Marketing Authorization in COVID-19, to the United Kingdom’s Medicines and Healthcare Products Regulatory Agency (MHRA)
Humanigen, Inc. (Nasdaq: HGEN) (“Humanigen”), a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm’, today announced it has ini
June 15, 2021 10:40
New Study Investigates the Impact of ORi-Guided Oxygen Titration on Hyperoxemia-Mediated Morbidity During One-Lung Ventilation
Masimo (NASDAQ: MASI) announced today the findings of a study published in the Turkish Journal of Medical Sciences in which Dr. Ayten Saracoglu and colleagues at the Marmara University Pendik Training
June 11, 2021 09:41
Gummy Vitamin Sales Rising in Asia as Focus on Preventing Micro-nutrient Deficiency Increases: Study
The gummy vitamin market in East Asia is anticipated to witness high demand across China and South Korea, opines award winning market research firm Fact.MR in a market study. Rising prevalence of chro
June 10, 2021 17:05
Safeguard DNA Diagnostics Launches Rhinostics Dry Collection Swabs for COVID Testing as Primary Collection Devices for Its Laboratories in the Philippines
Safeguard DNA Diagnostics Inc, SDDI, one of the largest chains of infectious disease laboratories in the Philippines, has introduced COVID sample collection using the Rhinosticsᵗᵐ dry nasal and nasoph
June 09, 2021 17:30
Invivoscribe Premieres 12-Color Flow Cytometry Capabilities at their Reference Labs in the US, Europe, and China
Today Invivoscribe, a global leader in precision diagnostics, announced the launch of a new 12-color multiparametric flow cytometry service in Shanghai, China, the newest reference laboratory in their
June 09, 2021 14:40
ANANDA Scientific and NYU Grossman School of Medicine Announce First Patient Enrolled in the Clinical Trial Evaluating Liquid Structure™ Cannabidiol (CBD) for Treatment of Post-Traumatic Stress Disorder (PTSD)
ANANDA Scientific Inc., a biotech pharmaceutical company, and NYU Grossman School of Medicine today announced that the first patient has been enrolled in a clinical trial evaluating Nantheia™ A1002N5S
June 08, 2021 16:40
Agendia’s MammaPrint® Test is the First to Demonstrate the Ability to Predict Benefit from Extended Endocrine Treatment in NSABP B-42 Trial
Agendia, Inc., a world leader in precision oncology for breast cancer, today announced positive results from an analysis using its 70-gene MammaPrint® assay on samples from the NSABP B-42 trial. These
June 08, 2021 16:30
Humanigen Announces Ken Trbovich Appointed as Senior Vice President, Investor Relations
Humanigen, Inc. (Nasdaq: HGEN) (“Humanigen”), a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm’ with its lead drug candidat
June 08, 2021 11:45
Phase 3 Clinical Trial Subgroup Analysis Across Solid Organ Transplant (SOT) Types Supports Efficacy of Maribavir Over Conventional Therapies in Post-Transplant Recipients With Cytomegalovirus (CMV) Infection (Refractory, With or Without Resistance)
Takeda Pharmaceutical Company Limited (TSE:4502/NYSE:TAK) (“Takeda”) today at the American Transplant Congress (ATC) 2021 Virtual Connect presented results from a new subgroup analysis of SOT recipien
June 08, 2021 10:30
Iksuda Therapeutics Closes $47 Million Financing Round
Iksuda Therapeutics (Iksuda), the developer of a new generation of antibody drug conjugates (ADCs) with raised therapeutic index, today announced it has completed a US $47 million (circa GB £34 millio
June 07, 2021 11:50
Analysis of MINDACT Study Confirms MammaPrint Accurately Identifies Extremely Indolent Ultra Low Risk Breast Cancers
Agendia, Inc., a world leader in precision oncology for breast cancer, today announced that data from the landmark MINDACT study will be shared at the 2021 American Society of Clinical Oncology (ASCO)
June 07, 2021 11:10
Agendia Presents Data from Innovative FLEX Study at ASCO 2021 Showing MammaPrint and BluePrint Utility in Wide Variety of Patient Populations
Agendia, Inc., a world leader in precision oncology for breast cancer, announced that new data from the first-of-its kind, national FLEX registry was debuted today at the 2021 American Society of Clin
June 07, 2021 10:50
ASCO 2021 Podium Presentation on Agendia FLEX Study Shows Clinical & Molecular Differences in Tumors of African American and Caucasian Patients with HR+ Breast Cancer, Underscores Importance of Genomic Insights to Understand Disparities in Outcomes
Agendia, Inc., a world leader in precision oncology for breast cancer, announced today that an oral presentation at the 2021 American Society of Clinical Oncology (ASCO) Annual Meeting revealed new da
June 04, 2021 17:35
Humanigen to Present at the 2021 LD Micro Invitational XI
Humanigen, Inc. (Nasdaq: HGEN), a clinical-stage biopharmaceutical company focused on preventing and treating an immune hyper-response called ‘cytokine storm’ with its lead drug candidate, lenzilumab,
June 04, 2021 14:00
Cardiac Insight Announces Expansion Into More Than 20 Asia-Pacific Markets with i.SigNal by Dreamtech Partnership
Cardiac Insight, Inc., a digital health innovator specializing in wearable cardiac sensors and automated electrocardiogram (ECG) analysis software announced today that it has entered into a distributi
June 04, 2021 13:30
Crown Bioscience Announces Expedited Access to Well-Established ATCC and NIH Cell Lines for Large-Scale Screening Panels
Crown Bioscience (CrownBio), a JSR Life Sciences Company, today announced that they have entered into separate, yet complementary, portfolio license agreements with the ATCC and the U.S. Department of
June 04, 2021 11:00
Organon Launches as New Global Women’s Health Company
Organon (NYSE: OGN), today celebrates its launch as a global women’s health company with employees and women from around the world, as the Organon executive leadership team rings the opening bell at t
25 per page50 per page75 per page100 per page